InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 13.41
+0.02 (0.15%)
Jul 9, 2026, 4:08 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 28.14 billion as of July 9, 2026. Its market cap has decreased by -2.09% in one year.
Market Cap
28.14B
Enterprise Value
22.16B
Revenue
2.87B
Ranking
n/a
PE Ratio
27.18
Stock Price
13.41
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 28.14B, an increase of 129.20%. That is a compound annual growth rate of 14.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 28.14B | 18.81% |
| Dec 31, 2025 | 23.69B | 93.83% |
| Dec 31, 2024 | 12.22B | -6.80% |
| Dec 29, 2023 | 13.11B | -44.09% |
| Dec 30, 2022 | 23.45B | 11.18% |
| Dec 31, 2021 | 21.09B | 21.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocytogen Pharmaceuticals (Beijing) | 47.76B |
| 3SBio | 44.26B |
| Shanghai Junshi Biosciences | 37.49B |
| Shanghai Henlius Biotech | 36.74B |
| Genscript Biotech | 29.04B |
| Keymed Biosciences | 24.91B |
| Duality Biotherapeutics | 18.81B |
| Zai Lab | 17.05B |